REST and Huntington disease: Using specific ASOs and a cellular model of HD, our present study validates mechanism by which a common splicing (∆E3) modulates REST activity, as well as its potential as a therapeutic target for HD—a neurodegenerative disease associated with excessive nuclear REST.